Aurobindo Pharma reported 8.59B in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Cipla CIPLA:IN 8.78B 95.1M
Dr.Reddys Laboratories DRRD:IN 24B 748M
Hindustan Unilever HUVR:IN 18.46B 1.63B
Sun Pharmaceuticals SUNP:IN 18.06B 475.3M
UPL UPLL:IN 11.37B 1.44B